Skip to main content
Premium Trial:

Request an Annual Quote

DHS Awards US Genomics $8.6M SBIR for Biosensor Development

NEW YORK (GenomeWeb News) - US Genomics said today it has been awarded an $8.6 million Small Business Innovation Research grant from the US Department of Homeland Security to continue developing a biological sensor to detect airborne pathogens.
The company said it received the one-year, Phase III award through the DHS's Bioagent Autonomous Networked Detectors program. 
The company also said it completed the second phase of the contract, today, for which it was awarded $16.2 million. The first phase of the contract, awarded in 2004, was worth $7.5 million.
US Genomics' CEO John Canepa said the company is making "tremendous progress" on developing a biodefense sensor based on its DNA mapping technology.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.